Joseph C. Beyer

Preclinical safety profile of trastuzumab emtansine (T-DM1): Mechanism of action of its cytotoxic component retained with improved tolerability

Kirsten Achilles Poon, Kelly M. Flagella, Joseph C. Beyer et al. · Toxicology and Applied Pharmacology · 2013 · 189 citations · Full text

Breast Oncology, Immunology, Cytotoxic Component +18

PHARMACOKINETICS AND RETINAL DISTRIBUTION OF RANIBIZUMAB, A HUMANIZED ANTIBODY FRAGMENT DIRECTED AGAINST VEGF-A, FOLLOWING INTRAVITREAL ADMINISTRATION IN RABBITS

Jacques Gaudreault, David Fei, Joseph C. Beyer et al. · Retina · 2007 · 185 citations

Immunogenicity/Hypersensitivity of Biologics

Michael W. Leach, James B. Rottman, M. Benjamin Hock et al. · Toxicologic Pathology · 2013 · 104 citations

Immunocytochemical Technique, Immunodeficiencies, Immunology +16

Retinal Toxicity, in vivo and in vitro, Associated with Inhibition of Nicotinamide Phosphoribosyltransferase

Tanja S. Zabka, Jatinder Singh, Preeti Dhawan et al. · Toxicological Sciences · 2014 · 83 citations · Full text

Ocular Disease, Optogenetics, Oxidative Stress +16

Depletion of B Cells by a Humanized Anti-CD20 Antibody PRO70769 in Macaca Fascicularis

Yulia Vugmeyster, Joseph C. Beyer, Kathy Howell et al. · Journal of Immunotherapy · 2005 · 79 citations

Laboratory Immunology, Humoral Response, Immunology +17